Copyright Reports & Markets. All rights reserved.

Global Targeted Drugs for Breast Cancer Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Targeted Drugs for Breast Cancer Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 HER-2 Targeted Drugs
      • 1.4.3 CDK4/6 Inhibitors
      • 1.4.4 PARP Targeted Drugs
      • 1.4.5 PI3K/AKT/mTor Pathway Inhibitors
      • 1.4.6 ER Targeted Drugs
      • 1.4.7 Aromatase Inhibitors
      • 1.4.8 Tubulin Inhibitors
      • 1.4.9 VEGF Targeted Drugs
      • 1.4.10 YTMS Targeted Drugs
      • 1.4.11 Other
    • 1.5 Market by Application
      • 1.5.1 Global Targeted Drugs for Breast Cancer Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Drug Center
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Targeted Drugs for Breast Cancer Market Size
    • 2.2 Targeted Drugs for Breast Cancer Growth Trends by Regions
      • 2.2.1 Targeted Drugs for Breast Cancer Market Size by Regions (2014-2025)
      • 2.2.2 Targeted Drugs for Breast Cancer Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Targeted Drugs for Breast Cancer Market Size by by Players
      • 3.1.1 Global Targeted Drugs for Breast Cancer Revenue by by Players (2014-2019)
      • 3.1.2 Global Targeted Drugs for Breast Cancer Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Targeted Drugs for Breast Cancer Market Concentration Ratio (CR5 and HHI)
    • 3.2 Targeted Drugs for Breast Cancer Key Players Head office and Area Served
    • 3.3 Key Players Targeted Drugs for Breast Cancer Product/Solution/Service
    • 3.4 Date of Enter into Targeted Drugs for Breast Cancer Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Targeted Drugs for Breast Cancer Market Size by Type (2014-2019)
    • 4.2 Global Targeted Drugs for Breast Cancer Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Targeted Drugs for Breast Cancer Market Size (2014-2019)
    • 5.2 Targeted Drugs for Breast Cancer Key Players in United States
    • 5.3 United States Targeted Drugs for Breast Cancer Market Size by Type
    • 5.4 United States Targeted Drugs for Breast Cancer Market Size by Application

    6 Europe

    • 6.1 Europe Targeted Drugs for Breast Cancer Market Size (2014-2019)
    • 6.2 Targeted Drugs for Breast Cancer Key Players in Europe
    • 6.3 Europe Targeted Drugs for Breast Cancer Market Size by Type
    • 6.4 Europe Targeted Drugs for Breast Cancer Market Size by Application

    7 China

    • 7.1 China Targeted Drugs for Breast Cancer Market Size (2014-2019)
    • 7.2 Targeted Drugs for Breast Cancer Key Players in China
    • 7.3 China Targeted Drugs for Breast Cancer Market Size by Type
    • 7.4 China Targeted Drugs for Breast Cancer Market Size by Application

    8 Japan

    • 8.1 Japan Targeted Drugs for Breast Cancer Market Size (2014-2019)
    • 8.2 Targeted Drugs for Breast Cancer Key Players in Japan
    • 8.3 Japan Targeted Drugs for Breast Cancer Market Size by Type
    • 8.4 Japan Targeted Drugs for Breast Cancer Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Targeted Drugs for Breast Cancer Market Size (2014-2019)
    • 9.2 Targeted Drugs for Breast Cancer Key Players in Southeast Asia
    • 9.3 Southeast Asia Targeted Drugs for Breast Cancer Market Size by Type
    • 9.4 Southeast Asia Targeted Drugs for Breast Cancer Market Size by Application

    10 India

    • 10.1 India Targeted Drugs for Breast Cancer Market Size (2014-2019)
    • 10.2 Targeted Drugs for Breast Cancer Key Players in India
    • 10.3 India Targeted Drugs for Breast Cancer Market Size by Type
    • 10.4 India Targeted Drugs for Breast Cancer Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Targeted Drugs for Breast Cancer Market Size (2014-2019)
    • 11.2 Targeted Drugs for Breast Cancer Key Players in Central & South America
    • 11.3 Central & South America Targeted Drugs for Breast Cancer Market Size by Type
    • 11.4 Central & South America Targeted Drugs for Breast Cancer Market Size by Application

    12 International Players Profiles

    • 12.1 Roche
      • 12.1.1 Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Targeted Drugs for Breast Cancer Introduction
      • 12.1.4 Roche Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.1.5 Roche Recent Development
    • 12.2 Teva
      • 12.2.1 Teva Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Targeted Drugs for Breast Cancer Introduction
      • 12.2.4 Teva Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.2.5 Teva Recent Development
    • 12.3 Mylan
      • 12.3.1 Mylan Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Targeted Drugs for Breast Cancer Introduction
      • 12.3.4 Mylan Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.3.5 Mylan Recent Development
    • 12.4 Hikma
      • 12.4.1 Hikma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Targeted Drugs for Breast Cancer Introduction
      • 12.4.4 Hikma Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.4.5 Hikma Recent Development
    • 12.5 Hengrui Medicine
      • 12.5.1 Hengrui Medicine Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Targeted Drugs for Breast Cancer Introduction
      • 12.5.4 Hengrui Medicine Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.5.5 Hengrui Medicine Recent Development
    • 12.6 Cipla
      • 12.6.1 Cipla Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Targeted Drugs for Breast Cancer Introduction
      • 12.6.4 Cipla Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.6.5 Cipla Recent Development
    • 12.7 Reliance Group
      • 12.7.1 Reliance Group Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Targeted Drugs for Breast Cancer Introduction
      • 12.7.4 Reliance Group Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.7.5 Reliance Group Recent Development
    • 12.8 Hetero
      • 12.8.1 Hetero Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Targeted Drugs for Breast Cancer Introduction
      • 12.8.4 Hetero Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.8.5 Hetero Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Targeted Drugs for Breast Cancer Introduction
      • 12.9.4 Pfizer Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.9.5 Pfizer Recent Development
    • 12.10 Eli Lilly
      • 12.10.1 Eli Lilly Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Targeted Drugs for Breast Cancer Introduction
      • 12.10.4 Eli Lilly Revenue in Targeted Drugs for Breast Cancer Business (2014-2019)
      • 12.10.5 Eli Lilly Recent Development
    • 12.11 Novartis
    • 12.12 CANbridge
    • 12.13 Puma Biotechnology
    • 12.14 AstraZeneca
    • 12.15 Chugai Pharmaceutical
    • 12.16 Eisai
    • 12.17 GlaxoSmithKline
    • 12.18 Bristol-Myers Squibb
    • 12.19 Otsuka Pharmaceutical
    • 12.20 Merck
    • 12.21 BioMarin
    • 12.22 Hengrui Pharmaceutical
    • 12.23 Beijing Biostar Technologies
    • 12.24 Bayer

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Targeted Drugs for Breast Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Targeted Drugs for Breast Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Targeted Drugs for Breast Cancer development in United States, Europe and China.

      The key players covered in this study
      Roche
      Teva
      Mylan
      Hikma
      Hengrui Medicine
      Cipla
      Reliance Group
      Hetero
      Pfizer
      Eli Lilly
      Novartis
      CANbridge
      Puma Biotechnology
      AstraZeneca
      Chugai Pharmaceutical
      Eisai
      GlaxoSmithKline
      Bristol-Myers Squibb
      Otsuka Pharmaceutical
      Merck
      BioMarin
      Hengrui Pharmaceutical
      Beijing Biostar Technologies
      Bayer

      Market segment by Type, the product can be split into
      HER-2 Targeted Drugs
      CDK4/6 Inhibitors
      PARP Targeted Drugs
      PI3K/AKT/mTor Pathway Inhibitors
      ER Targeted Drugs
      Aromatase Inhibitors
      Tubulin Inhibitors
      VEGF Targeted Drugs
      YTMS Targeted Drugs
      Other

      Market segment by Application, split into
      Hospital
      Clinic
      Drug Center
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Targeted Drugs for Breast Cancer status, future forecast, growth opportunity, key market and key players.
      To present the Targeted Drugs for Breast Cancer development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Targeted Drugs for Breast Cancer are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now